US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3900
  • 0.00000.00%
Close Apr 18 16:00 ET
  • 1.3700
  • -0.0200-1.44%
Post 19:58 ET
291.03MMarket Cap-4964P/E (TTM)

About Akebia Therapeutics Company

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Company Profile

SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees167
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098
Websitehttp://www.akebia.com

Company Executives

  • Name
  • Position
  • Salary
  • John P. Butler
  • Director, President and Chief Executive Officer
  • 3.04M
  • Nicole R. Hadas
  • Senior Vice President, Chief Legal Officer and Corporate Secretary
  • 1.24M
  • Richard C. Malabre
  • Chief Accounting Officer
  • --
  • Michel Dahan
  • Senior Vice President and Chief Operating Officer
  • 1.29M
  • Dr. Steven Keith Burke, M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.38M
  • Adrian Adams
  • Chairman of the Board
  • 110.21K
  • Dr. Steven C. Gilman, PhD
  • Independent Director
  • 70.73K
  • Cynthia Smith
  • Independent Director
  • 80.68K
  • Ronald E. Frieson
  • Independent Director
  • 71.69K
  • Dr. Myles Wolf, M.D.
  • Independent Director
  • 77.32K
  • LeAnne M. Zumwalt
  • Independent Director
  • 71.96K
  • Michael W. Rogers
  • Independent Director
  • 77.76K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg